Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × inavolisib × Clear all

NCT04551521 2025-01-08

CRAFT: The NCT-PMO-1602 Phase II Trial

Phase 2 Completed

Neoplasm Metastasis